NeuroSense Therapeutics Ownership | Who Owns NeuroSense Therapeutics?


OverviewChart

NeuroSense Therapeutics Ownership Summary


NeuroSense Therapeutics is owned by 0.84% institutional investors, 30.98% insiders, and 68.18% retail investors. Xtx topco is the largest institutional shareholder, holding 0.23% of NRSN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.07% of its assets in NeuroSense Therapeutics shares.

NRSN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeuroSense Therapeutics0.84%30.98%68.18%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Xtx topco41.90K0.23%$50.28K
Meitav investment house40.00K0.22%$48.00K
Commonwealth equity services16.25K0.09%$20.00K
Geode capital management15.87K0.09%$19.04K
Two sigma securities15.02K0.08%$18.02K
Warberg asset management10.70K0.06%$12.84K
Morgan stanley1.50K0.01%$1.68K
Cwm1.00K0.01%$1.00K
Qube research---
Cantor fitzgerald, l. p.---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Xtx topco41.90K0.00%$50.28K
Two sigma securities15.02K0.00%$18.02K
Warberg asset management10.70K0.00%$12.84K
Meitav investment house40.00K0.00%$48.00K
Cwm1.00K-$1.00K
Jane street group---
Cantor fitzgerald, l. p.---
Stratos wealth partners---
Ubs group---
Hrt financial lp---

Top Buyers

HolderShares% AssetsChange
Two sigma securities15.02K0.00%15.02K
Warberg asset management10.70K0.00%10.70K
Geode capital management15.87K-3.91K
Commonwealth equity services16.25K-3.63K
Meitav investment house40.00K0.00%-

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.58M
Cantor fitzgerald, l. p.---79.49K
Renaissance---71.10K
Jane street group---64.64K
Hrt financial lp---64.39K

New Positions

HolderShares% AssetsChangeValue
Two sigma securities15.02K0.00%15.02K$18.02K
Warberg asset management10.70K0.00%10.70K$12.84K

Sold Out

HolderChange
Qube research-54.00
Ubs group-11.93K
Woodline partners lp-19.58K
Stratos wealth partners-20.00K
Hrt financial lp-64.39K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202511-15.38%194,892-69.85%-6.54%3-70.00%3200.00%
Dec 31, 20241385.71%646,513186.89%3229.84%10150.00%1-
Sep 30, 20247-225,356-86.52%11.06%4100.00%--100.00%
Jun 30, 20247-12.50%1,671,167899.94%10918.60%2-33.33%1-
Mar 31, 20248-167,12618.03%184.21%3-40.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index15.87K0.07%-

NRSN Ownership FAQ


Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics shareholders are primarily institutional investors at 0.84%, followed by 30.98% insiders and 68.18% retail investors. The average institutional ownership in NeuroSense Therapeutics's industry, Biotech Stocks , is 63.96%, which NeuroSense Therapeutics falls below.

Who owns the most shares of NeuroSense Therapeutics?

NeuroSense Therapeutics’s largest shareholders are Xtx topco (41.9K shares, 0.23%), Meitav investment house (40K shares, 0.22%), and Commonwealth equity services (16.25K shares, 0.09%). Together, they hold 0.54% of NeuroSense Therapeutics’s total shares outstanding.

Does Blackrock own NeuroSense Therapeutics?

BlackRock is not among the top 10 institutional shareholders of NeuroSense Therapeutics.

Who is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested?

Xtx topco is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 41.9K NeuroSense Therapeutics shares, valued at 50.28K$.

Who is the top mutual fund holder of NeuroSense Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NeuroSense Therapeutics shares, with 0.07% of its total shares outstanding invested in 15.87K NeuroSense Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools